Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. II. Field trial
|
|
- Elfrieda Hancock
- 6 years ago
- Views:
Transcription
1 Veterinary Immunology and Immunopathology 93 (2003) Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. II. Field trial Gabriel Leitner a,*, Nathan Yadlin a, Evgenia Lubashevsy b, E. Ezra c, Anita Glickman a, Marcelo Chaffer a, Marta Winkler a, Arthur Saran a, Zeev Trainin b a National Mastitis Reference Center, Bet Dagon, Israel b Immunology Department, Kimron Veterinary Institute, Ministry of Agriculture and Rural Development, P.O. Box 12, Bet Dagon 50250, Israel c Israel Cattle Breeders Association, Caesaria, Israel Received 16 May 2002; received in revised form 11 February 2003; accepted 4 March 2003 Abstract A recently described new Staphylococcus aureus vaccine MASTIVAC I (Patent no. PTC/IL98/00627) against S. aureus udder infection elicited protection against experimentally induced infection in cows. In the present paper we describe a largescale vaccination field trial. A total of 452 Israeli Holstein heifers were included in the study over two consecutive years. Approximately half of the heifers (228) were vaccinated while the others (224) served as a control group. Antibody response was detected in all vaccinated animals 4 5 weeks post-primary immunization and it was sustained throughout the experimental period ( days). S. aureus infection could be detected in only 3 out of 228 animals (1.3%) in the vaccinated group and in 6 out of 224 (2.7%) in the control group. These numbers were too low to be statistically evaluated. However, when somatic cell counts (SCC) and milk yields were considered, a significant difference was found between the two groups, namely, the vaccinated cows in first and second lactation had 42 and 54%, respectively, lower SCCs and milk yields 0.5 kg per day higher than the non-vaccinated control cows. These results suggest that the new vaccine elicits a non-specific health improvement of the udder in addition to specific protection against S. aureus. # 2003 Elsevier Science B.V. All rights reserved. Keywords: Cattle; Mastitis; Vaccine; S. aureus 1. Introduction Staphylococcus aureus is one of the major pathogenic agents of the udder, in which it causes mainly subclinical infection. This type of mastitis impairs Abbreviations: SCC, somatic cell count; S. aureus, Staphylococcus aureus; IDF, International Dairy Federation; CC, Coulter 1 Counter; LSCC, log 2 SCC; CNS, coagulase-negative staphylococci * Corresponding author. Tel.: þ ; fax: þ address: gleit_vs@netvision.net.il (G. Leitner). alveolar function, reduces milk yield and has a deleterious effect on milk composition, including increased milk somatic cell counts (SCC) (Gudding et al., 1984; Nickerson, 1989). Much effort has been devoted to the development of a vaccine against S. aureus mastitis in bovines (Yoshida et al., 1984; Watson and Schwartzkoff, 1990; Nelson et al., 1991; Watson, 1992; Watson et al., 1996; Mamo et al., 1994; Nordhoug et al., 1994; Calzolari et al., 1997; Giraudo et al., 1997) but a substantial solution has not been achieved so far. Recently we described /03/$ see front matter # 2003 Elsevier Science B.V. All rights reserved. doi: /s (03)00062-x
2 154 G. Leitner et al. / Veterinary Immunology and Immunopathology 93 (2003) the development of a the new S. aureus vaccine, designated MASTIVAC I (Patent no. PTC/IL98/ and Leitner et al., this issue, mouse model). The new vaccine is composed of three field strains, which exhibit a broad spectrum of antigenic and immunogenic properties. Upon administration of the vaccine, no side effects or pathogenic findings were observed. In controlled experiments the vaccine was found effective against challenge with a virulent field strain of S. aureus (Leitner et al., this issue, challenge trials) the results showed significant protection from infection (70%). Moreover, all quarters challenged in the vaccinated cows, regardless of whether or not they were successfully infected with S. aureus, demonstrated only very mild inflammatory reactions in their udder tissues as expressed in their low SCCs (< ) (Leitner et al., this issue, challenge trials). In the present paper we describe a large-scale field study, involving 452 Israeli Holstein heifers from seven dairy farms, over two consecutive years. 2. Materials and methods 2.1. Animals A total of 473 Israeli Holstein heifers from seven dairy farms located in different regions of Israel were included in the study. S. aureus was prevalent in all herds, being present in 8 25% of the animals. Data on the phenotypic characteristics of the S. aureus strains revealed several different subtypes among the seven dairy farms (Table 1). All heifers included in this study underwent serological tests for S. aureus antibodies and only those which did not possess specific Table 1 Hemolysis patterns and phage types of the local S. aureus isolates from cows in each of the seven experimental farms Farm Hemolysis Phage type a þ b D11 þ /HK 2, 84 [90] b 6, 42E, 47, 53, 54, 75, 83A, 85, 90, D11 þ /HK b 3A/3C, 55, b 80/55 [29, 52, 52A, 3/C, 92] A/3C, 71 [55] ND ND a þ b 84, 92 [53, 75, D11 þ /HK 2 ] antibodies (452 animals) were included. Post-partum, cows were milked three times daily. Food was offered in mangers located in free stall barns Vaccine and vaccination A comprehensive description of the vaccine has been described under Patent nos and PTC/ IL98/00627 and in the previous manuscript Staphylococcus aureus vaccine against mastitis in dairy cows, composition and evaluation in mouse model (Leitner et al., companion paper, this issue). The vaccine is derived from three field strains of S. aureus; it comprises insoluble bacterial fragments (derived by mechanical agitation) of two of the strains and a supernatant fraction containing secreted antigens of the third strain, and contains a broad spectrum of antigenic determinants. Each cow was immunized subcutaneously under the tail root with 1 ml of the vaccine emulsified with incomplete Freund s adjuvant and in the area of the supra-mammary lymph node with 1 ml of the vaccine without the adjuvant. A second dose of the vaccine without adjuvant was administered by means of the same procedure, days after the primary immunization Bacteriological examinations Bacteriological examinations were conducted as described in a companion paper (Leitner et al., this issue. 1. Challenge trials) Milk content and SCC SCCs were determined with a Coulter 1 Counter (CC) Model Z1 (Coulter Electronics Ltd., Beds., UK) according to the revised protocol of the A2B subgroup of the Mastitis Experts of the IDF (1991) or with the Fossomatic 360 instrument at the Israeli Cattle Breeders Association, Milk Control Laboratory in Caesarea Immunological assay ELISA: The assay was performed as previously described (Leitner et al., 2000a), with VLVL8407 S. aureus as antigen. To each plate, positive and negative serum standards were added. The optical
3 G. Leitner et al. / Veterinary Immunology and Immunopathology 93 (2003) density of each tested sample was normalized by linear regression in order to calculate the titer Study layout In each of the seven farms, the heifers were divided into groups according to the time of expected calving. Ten to eight weeks prior to the first calving in each group, the heifers were bled and assigned randomly into two subgroups: immunized and unimmunized (control). Heifers in the immunized subgroup were vaccinated at that time; 4 5 weeks later, all heifers were bled and the immunized animals were revaccinated. After first calving, each animal in the experiment was bled and milk samples were collected two or three times: at 2 4 weeks, 2 3 months and 5 6 months postpartum. The data on farm, year and treatment of the 452 heifers included in this experiment are summarized in Table 2. Data on milk composition, SCC, and yield for 7 9 months from the time of were obtained from the Israeli Cattle Breeders Association s Herd Book. On two of the farms ( and ), all heifers that remained for the second calving were bled at the time of drying-off and 26 cows from the immunized group were revaccinated. This formed three new groups of second-lactating cows: vaccinated as a heifer and revaccinated as a cow (26 animals), vaccinated only as a heifer (13 animals) and unvaccinated control (45 animals) (Table 4). SCC and milk yield over 7 9 months from the time of second parturition were obtained from the Israeli Cattle Table 2 Distribution of heifers according to farm, year, and treatment Farm Year Vaccinated Control Total Total Breeders Association s Herd Book and analyzed as for the first calving Statistical analysis Data were analyzed by means of the SAS general linear model (GLM) procedure (SAS, 1990). Dependent variables were: milk yield (kg), fat, protein, and lactos contents, SCC, and SCC transformed to log 2 (LSCC). The independent variables were: treatment, herd, cow, number of days in milk, and (number of days in milk) squared. The effects on the dependent variables were examined with the model: Y ijkl ¼ m þ T i þ H j þ R k þ C ijk ðthrþ þ DIM þ DIM 2 þ e ijkl where Y is the dependent variables; m the overall mean; T i the treatment, i ¼ 1; 2; H j the herd, j ¼ 1;...; 7; R k the year, k ¼ 1; 2; C ijk the cow at treatment i in herd j in year k ; DIM the days in milk; and DIM 2 ¼ DIM DIM. 3. Results During the entire period of the experiment, none of the cows showed any abnormal symptoms of sensitivity to the vaccine except for local swelling for up to 10 days after vaccination. Of the new calves 95% were born alive and healthy, with no teratogenic features. No difference could be detected in calf survival rate between the immunized and the control cows. Antibody response to antigen of VLVL8407 S. aureus could be detected in all vaccinated animals when first tested, 4 5 weeks after the primary immunization (Fig. 1), and the highest antibody level was detected at that time. After calving, antibody titer decreased moderately, with some fluctuations up to 150 days post-vaccination (Fig. 1). Further tests were carried out in two of the seven experimental farms at the time of drying-off ( days): all heifers tested (53% of all heifers vaccinated) at that time maintained antibodies at a level similar to that determined at 150 days. Although all vaccinated cows responded to the vaccine, the mean antibody level varied among the herds, and in two of the herds the overall response was lower than in the others. The numbers of cows from whose milk S. aureus was isolated were 3 out of
4 156 G. Leitner et al. / Veterinary Immunology and Immunopathology 93 (2003) Fig. 1. Mean and S.E. of S. aureus-specific antibody titers of 228 heifers from seven farms, vaccinated against this agent and 224 control. 228 (1.3%) in the vaccinated groups and 6 out of 224 (2.7%) in the control groups. Coagulase-negative staphylococcus (CNS) was the predominant bacterial isolate from the milk samples, with no difference observed between the frequencies of isolation from vaccinated and control cows. The SCCs and milk yields (Herd Book) for 7 9 months from the time of parturition were analyzed, and large differences in SCC were found among the herds, but in all seven herds the vaccinated heifers had lower SCCs than the control animals. Vaccinated heifers had a mean (over herd and year) value of 101: cells/ml (S.E. 12.1), compared with 175: cells/ml (S.E. 14.8) in the controls. This difference was found to be significant (P < 0:0001) (Table 3). Thus, vaccinated heifers had 42.3% lower SCCs than the control cows. There were also differences among herds in their milk yields; however; in all seven herds the vaccinated heifers had either the same or higher milk yield than the controls: the mean milk yield of the vaccinated heifers was significantly higher (P < 0:01), by 0.5 kg per day than that of the control animals (Table 3). During the second lactation, six of the cows (from the three groups) became clinically infected with Gram negative bacteria and therefore, were not considered for the analysis. Revaccinated cows exhibited a mean (over herd) value of 100: cells/ml (S.E. 28.8), compared with 137: cells/ml (S.E. 45.0) for vaccinated cows and 220: cells/ml (S.E. 45.6) for the controls (Table 4). Thus, the SCCs of revaccinated cows were 54.33% lower than that of the control cows and 26.7% lower than that of the vaccinated cows; the SCC of the vaccinated cows was Table 3 Daily milk yield (kg) and SCC in milk of vaccinated and control heifers Group Milk (kg per day) SCC (10 3 ) Mean S.E. Mean S.E. Control Vaccinated Vaccinated control þ0.5 (1.4%) 74.1 (42.3%) P > F Table 4 Distribution of second-lactating cows according to treatment: revaccinated, vaccinated, and control animals evaluated according to their SCC during the lactation Group SCC (10 3 ) Mean S.E. Control (45) Vaccinated (13) Revaccinated (26) Vaccinated control 83.1 (37.7%) Revaccinated control (54.3%) Revaccinated vaccinated 36.8 (26.7%) P > F 0.05
5 G. Leitner et al. / Veterinary Immunology and Immunopathology 93 (2003) % lower than that of the control animals. However, the only significant differences were those between revaccinated or vaccinated cows and the controls; the difference between the vaccinated and the revaccinated cows was not significant (Table 4). No significant differences in daily milk yield were found among the groups. 4. Discussion Vaccination with the experimental vaccine against S. aureus mastitis did not affect pregnancy and no difference was observed between vaccinated and control heifers in the numbers of healthy calves delivered. All heifers responded to the vaccine with the production of specific antibodies, but the peak distributions of antibody levels were based on observations at the herd level rather than at the individual animal level (Fig. 1), therefore, the possibility that local herd factors influence the immune response to antigens cannot be ruled out. In spite of these local differences between herds, the difference in udder health between the vaccinated and control cows, as indicated by the SCCs, were significant for each herd considered separately as well as for the total of 452 animals tested. Although at the time of vaccination the prevalence of S. aureus infection in the cows of tested herds ranged between 8 and 25%, the numbers of firstlactating heifers and second-lactating cows infected with S. aureus in this study were low, therefore, it is not possible to analyze the rate of specific protection stimulated by the vaccine. It was shown previously (Leitner et al., 2000b) that the SCC in an uninfected mammary gland is lower than cells/ml and that the presence in an udder quarter of most contaminating bacteria, including CNS (Chaffer et al., 1999), causes an increase in the SCC, to 10 5 to 10 6 cells/ml. Moreover, contaminants in one quarter have no influence regarding SCC on the other quarters of the same cow; therefore, the total SCC in the milk indicates the health status of the udder at whole. Hence, the more quarters infected the higher SCC in the bulk milk. The present study has shown that the SCCs in vaccinated heifers and second-lactating cows were significantly lower than those determined in control animals, though not extremely high. Nevertheless, the high number of animal tested in the current experiment indicates that the overall udder health of vaccinated cows was clearly better than that of the control group. These results are in agreement with those of a previous challenge trial (Pankey et al., 1985) found that the vaccinated cows had significantly lower SCCs than the control cows. The significantly lower SCCs in the second-lactating cows that were not revaccinated before the second calving, together with the detection of the specific antibody to S. aureus in those cows, indicate that vaccination before first calving resulted in a persistently healthy udder condition. It seems, however, that revaccination strengthens the likelihood that the mammary gland will remain uninfected. Unfortunately, it was impossible to determine which quarters of a cow were contaminated with CNS, because all the quarters were sampled together. Nevertheless, the significantly lower SCCs in vaccinated than in unvaccinated cows suggest that either the number of quarters infected with CNS was lower or that the cow s response to the presence of the CNS infection in a quarter was less than that in unvaccinated cows. There was a non-specific effect of the vaccine on udder health. Nevertheless, the vaccine appears to have a heterologous effect since the S. aureus types on the seven farms were quite different. Therefore, it seems, that the vaccine maintains the SCCs similar to those of the uninfected mammary gland. The 0.5 kg per day increases in milk yield in the vaccinated heifers in the first lactation may have resulted from the overall improvement of udder health in vaccinated cows. Thus, the novel vaccine seems to exert positive effects on both the quantity and the quality of the milk production. The significance of such results to the dairy industry is clearly considerable. References Calzolari, A., Giraudo, J.E., Rampone, H., Odierno, L., Giraudo, A.T., Frigerio, C., Bettera, S., Raspanti, C., Hernandez, J., Wehbe, M., Mattea, M., Forrari, M., Larriestra, A., Nagel, R., Field trials of vaccine against bovine mastitis. 2. Evaluation in two commercial dairy herds. J. Dairy Sci. 80, Chaffer, M., Leitner, G., Winkler, M., Glickman, A., Krifucks, O., Ezra, E., Saran, A., Coagulase-negative staphylococci and mammary gland infections in cows. J. Vet. Med. B 46,
6 158 G. Leitner et al. / Veterinary Immunology and Immunopathology 93 (2003) Giraudo, J.E., Calzolari, A., Rampone, H., Rampone, A., Giraudo, A.T., Bogni, C., Larriestra, A., Nagel, R., Field trials of vaccine against bovine mastitis. 1. Evaluation in heifers. J. Dairy Sci. 80, Gudding, R., McDonald, J.S., Cheville, N.F., Pathogenesis of Staphylococcus aureus: bacteriological, histologic, and ultrastructural pathologic findings. Am. J. Vet. Res. 45, International Dairy Federation, International IDF Standard 148. Milk Enumeration of Somatic Cells. Mastitis Experts, Brussels. Leitner, G., Yadlin, B., Glickman, A., Chaffer, M., Saran, A., 2000a. Systemic and local immune response of cows to intramammary infection with Staphylococcus aureus. Res. Vet. Sci. 69, Leitner, G., Chaffer, M., Krifucks, O., Glickman, A., Ezra, E., Saran, A., 2000b. Milk leukocyte population in heifers free of udder infection. J. Vet. Med. B 47, Mamo, W., Jonsson, P., Flock, J.I., Lindberg, M., Muller, H.P., Wadstom, T., Nelson, L., Vaccination against Staphylococcus aureus mastitis: immunological response of mice vaccinated with fibronectin binding protein (FnBP-A) to challenge with S. aureus. Vaccine 12, Nelson, L., Flock, J.I., Hook, M., Lindberg, M., Muller, H.P., Wadstrom, T., Adhesions in staphylococcal mastitis as vaccine components. Flem. Vet. J. 62, Nickerson, S.C., Immunological aspects of mammary involution. J. Dairy Sci. 72, Nordhoug, M.L., Nesse, L.L., Norcross, N.L., Gudding, R., A field trial with an experimental vaccine against Staphylococcus aureus mastitis in cattle. I. Clinical parameters. J. Dairy Sci. 77, Pankey, J.W., Boddie, N.T., Watts, J.L., Nickerson, S.C., Evaluation of protein A and a commercial bacterin as vaccines against Staphylococcus aureus mastitis by experimental challenge. J. Dairy Sci. 68, SAS, SAS/STAT 1 User s Guide, Version 6, 4th ed., vol. 2. SAS Institute Inc., Cary, NC. Watson, D.L., Vaccination against experimental staphylococcal mastitis in dairy heifers. Res. Vet. Sci. 53, Watson, D.L., Schwartzkoff, C.L., A field trial to test the efficacy of a staphylococcal mastitis vaccine in commercial dairies in Australia. In: Proceedings of the International Symposium on Bovine Mastitis, National Mastitis Council, Arlington, pp Watson, D.L., McColl, M.L., Davies, H.I., Field trial of a staphylococcal mastitis vaccine in dairy heifers: clinical, subclinical and microbiological assessments. Aust. Vet. J. 74, Yoshida, K., Ichiman, Y., Narikawa, S., Evans, G.B., Staphylococcal capsular for preventing mastitis in two herds in Georgia. J. Dairy Sci. 67,
Milk Quality Management Protocol: Fresh Cows
Milk Quality Management Protocol: Fresh Cows By David L. Lee, Professor Rutgers Cooperative Extension Fresh Cow Milk Sampling Protocol: 1. Use the PortaSCC milk test or other on-farm mastitis test to check
More informationENVIRACOR J-5 aids in the control of clinical signs associated with Escherichia coli (E. coli) mastitis
GDR11136 ENVIRACOR J-5 aids in the control of clinical signs associated with Escherichia coli (E. coli) mastitis February 2012 Summary The challenge data presented in this technical bulletin was completed
More informationMASTITIS VACCINE ANTIBODIES (MASTIVAC I) PASIVELY PROTECT MICE AGAINST STAPHYLOCOCCUS AUREUS ISOLATES FROM USA, GERMANY AND ITALY
MASTITIS VACCINE ANTIBODIES (MASTIVAC I) PASIVELY PROTECT MICE AGAINST STAPHYLOCOCCUS AUREUS ISOLATES FROM USA, GERMANY AND ITALY Leitner G.,'* Krifucks O.', Weisblit L.', Arnon E. 1, Yagana K. 2 and Trainin
More informationSubclinical mastitis in small ruminants: prevalence, comparative aspects and prevention
Subclinical mastitis in small ruminants: prevalence, comparative aspects and prevention Dr. Gabriel Leitner, National Mastitis Reference Center, Kimron Veterinary Institute, Israel Dr. Nissim Silanikove
More informationUdder infection and milk somatic cell count, NAGase activity and milk composition fat, protein and lactose in Israeli-Assaf and Awassi sheep
Small Ruminant Research 49 (2003) 157 164 Udder infection and milk somatic cell count, NAGase activity and milk composition fat, protein and lactose in Israeli-Assaf and Awassi sheep G. Leitner a,, M.
More informationUse of a novel adjuvant to enhance the antibody response to vaccination against Staphylococcus aureus mastitis in dairy heifers.
Use of a novel adjuvant to enhance the antibody response to vaccination against Staphylococcus aureus mastitis in dairy heifers. C. L. Hall, S. C. Nickerson, L.O. Ely, F. M. Kautz, and D. J. Hurley Abstract
More informationVaccination as a Tool to Reduce Mastitis and Improve Milk Quality in Dairy Goats. F.M. Kautz, S. C. Nickerson, and L. O. Ely.
Vaccination as a Tool to Reduce Mastitis and Improve Milk Quality in Dairy Goats F.M. Kautz, S. C. Nickerson, and L. O. Ely Abstract The purpose of this investigation was to evaluate the efficacy of a
More informationMastitis MANAGING SOMATIC CELLS COUNTS IN. Somatic Cell Count Are Affected by. Somatic Cells are NOT Affected by:
MANAGING SOMATIC CELLS COUNTS IN COWS AND HERDS Pamela L. Ruegg, DVM, MPVM University of Wisconsin, Madison Bacterial infection of the udder 99% occurs when bacterial exposure at teat end exceeds ability
More informationUse of a staphylococcal vaccine to reduce prevalence of mastitis and lower somatic cell counts in a registered Saanen dairy goat herd
Use of a staphylococcal vaccine to reduce prevalence of mastitis and lower somatic cell counts in a registered Saanen dairy goat herd F.M. Kautz, S. C. Nickerson *, and L. O. Ely Department of Animal and
More informationOptions for Handling Mastitis during Lactation in Modern Dairy Farms
Options for Handling Mastitis during Lactation in Modern Dairy Farms Leitner, G., * Jacoby, S., 2 Frank, E. 2 and Shacked, R. 2 National Mastitis Reference Center, Kimron Veterinary Institute, P.O. Box
More informationEffect of omitting post-milking teat disinfection on the mastitis infection rate of dairy cows over a full lactation
57 th Annual Meeting of the European Association for Animal Production Antalya (Turkey), September 17-20, 2006 Session: M19 Free communications animal management and health Effect of omitting post-milking
More informationMastitis cows and immunization
In Spain, the antibiotherapy against mastitis moves 12,000,000 with an interannual growth of 10.2%. Only 4 of these millions are drying antibiotherapy. Conclusion: farmers spend a lot of money on mastitis
More informationMATERIALS AND METHODS
Effects of Feeding OmniGen-AF Beginning 6 Days Prior to Dry-Off on Mastitis Prevalence and Somatic Cell Counts in a Herd Experiencing Major Health Issues S. C. Nickerson 1, F. M. Kautz 1, L. O. Ely 1,
More informationMastitis: Background, Management and Control
New York State Cattle Health Assurance Program Mastitis Module Mastitis: Background, Management and Control Introduction Mastitis remains one of the most costly diseases of dairy cattle in the US despite
More informationField Efficacy of J-VAC Vaccines in the Prevention of Clinical Coliform Mastitis in Dairy Cattle
Field Efficacy of J-VAC Vaccines in the Prevention of Clinical Coliform Masitis in Dairy.. Page 1 of 5 Related References: Field Efficacy of J-VAC Vaccines in the Prevention of Clinical Coliform Mastitis
More informationPresented at Central Veterinary Conference, Kansas City, MO, August 2013; Copyright 2013, P.L Ruegg, all rights reserved
MILK MICROBIOLOGY: IMPROVING MICROBIOLOGICAL SERVICES FOR DAIRY FARMS Pamela L. Ruegg, DVM, MPVM, University of WI, Dept. of Dairy Science, Madison WI 53705 Introduction In spite of considerable progress
More informationApril Boll Iowa State University. Leo L. Timms Iowa State University. Recommended Citation
AS 652 ASL R2102 2006 Use of the California Mastitis Test and an On-Farm Culture System for Strategic Identification and Treatment of Fresh Cow Subclinical Intramammary Infections and Treatment of Clinical
More informationGina M Pighetti & Raul Almeida. University of Tennessee
Gina M Pighetti & Raul Almeida University of Tennessee Ultimate goal most vaccines Prevent infection Typically by increasing production of antibodies specific to an organism BUT, mastitis vaccines face
More informationInterpretation of Bulk Tank Milk Results
Interpretation of Bulk Tank Milk Results Introduction Culturing bulk tank milk (BTM) to monitor milk quality has limitations based on the amount and frequency of sampling and the amount and types of microorganisms
More informationUpdate on Staphylococcus aureus Mastitis. John R. Middleton College of Veterinary Medicine, University of Missouri, Columbia
Update on Staphylococcus aureus Mastitis John R. Middleton College of Veterinary Medicine, University of Missouri, Columbia 1 Staphylococcus aureus Gram-positive, facultatively anaerobic, non-motile, non-sporulating,
More informationEffect of subclinical intramammary infection on somatic cell counts, NAGase activity and gross composition of goats milk
Journal of Dairy Research (2004) 71 Journal of Dairy Research 2004 Printed in the United Kingdom Effect of subclinical intramammary infection on somatic cell counts, NAGase activity and gross composition
More informationMastitis in ewes: towards development of a prevention and treatment plan
SCHOOL OF LIFE SCIENCES, UNIVERSITY OF WARWICK Mastitis in ewes: towards development of a prevention and treatment plan Final Report Selene Huntley and Laura Green 1 Background to Project Mastitis is inflammation
More informationMilk Quality Evaluation Tools for Dairy Farmers
AS-1131 Mastitis Control Programs Milk Quality Evaluation Tools for Dairy Farmers P J. W. Schroeder, Extension Dairy Specialist roducers have a variety of informational tools available to monitor both
More informationDecision tree analysis of treatment strategies for mild and moderate cases of clinical mastitis occurring in early lactation
J. Dairy Sci. 94 :1873 1892 doi: 10.3168/jds.2010-3930 American Dairy Science Association, 2011. Decision tree analysis of treatment strategies for mild and moderate cases of clinical mastitis occurring
More informationHerd Navigator and mastitis management
Herd Navigator and mastitis management 1. What is mastitis? in some cases of E. coli mastitis the milk production in the affected Mastitis is the most common and costly disease in dairy herds. In quarter
More informationDeLaval Cell Counter ICC User Strategies Guide
Introduction 1. Bulk Tank Sampling Somatic cell count is one of the key indicators of udder health and has a major impact on milk production and farm costs. The DeLaval ICC mobile device allows for somatic
More informationLong influence of Escherichia coli intramammary infections on milk quality
1 2 3 4 5 6 7 8 Long influence of Escherichia coli intramammary infections on milk quality Shlomo Blum & Gabriel Leitner National Mastitis Reference Center, Kimron Veterinary Institute, Ministry of Agriculture
More informationControlling Contagious Mastitis
Controlling Contagious Mastitis John R. Middleton College of Veterinary Medicine, University of Missouri Quiz High SCC Objectives Definitions Causes Detection/Diagnosis Control Treatment Conclusion Definitions
More informationUsing DHIA and bacteriology to investigate herd milk quality problems.
Using DHIA and bacteriology to investigate herd milk quality problems. Nigel B. Cook BVSc MRCVS Clinical Assistant Professor in Food Animal Production Medicine University of Wisconsin-Madison, School of
More informationMASTITIS CASE MANAGEMENT
MASTITIS CASE MANAGEMENT The 2nd University of Minnesota China Dairy Conference Hohhot Sarne De Vliegher Head of M-team UGent & Mastitis and Milk Quality Research Unit @ UGent OVERVIEW Mastitis case management
More informationWalter M. Guterbock, DVM, MS Veterinary Medicine Teaching and Research Center University of California, Davis
Walter M. Guterbock, DVM, MS Veterinary Medicine Teaching and Research Center University of California, Davis 1993 WESTERN LARGE HERD MANAGEMENT CONFERENCE V LAS VEGAS NEVADA 27 Alternatives To Antibiotic
More informationInfluence of Experimentally- induced clinical mastitis on Reproductive Performance of Dairy Cattle
Influence of Experimentally- induced clinical mastitis on Reproductive Performance of Dairy Cattle Dr. Mitch Hockett Department of Animal Science North Carolina State University Characteristics of Mastitis
More informationLOCAL TOLERANCE OF INTRAMAMMARY PREPARATIONS IN COWS
LOCAL TOLERANCE OF INTRAMAMMARY PREPARATIONS IN COWS Guideline Title Local Tolerance of Intramammary Preparations in Cows Legislative Basis Directive 81/852/EEC as amended Date of First Adoption November
More informationMILK COMPOSITIONAL CHANGES DURING MASTITIS
MASTITIS PA R T 2 MILK COMPOSITIONAL CHANGES DURING MASTITIS Increased SCC Na Cl Whey protein (e.g. serum albumin, Ig, lactoferrin) Decreased Production α-lactalbumin & Lactose Casein K MILK LOSS LACTOFERRIN
More informationPractical Strategies for Treating Mastitis Pamela L. Ruegg, DVM, MPVM University of Wisconsin, Madison
Practical Strategies for Treating Mastitis Pamela L. Ruegg, DVM, MPVM University of Wisconsin, Madison Introduction Mastitis is the most frequent and costly disease of dairy cattle. Losses due to mastitis
More informationGuideline on the conduct of efficacy studies for intramammary products for use in cattle
1 2 3 18 October 2013 EMEA/CVMP/EWP/141272/2011 Committee for Medicinal products for Veterinary Use (CVMP) 4 5 6 Guideline on the conduct of efficacy studies for intramammary products for use in cattle
More informationHow to Decrease the Use of Antibiotics in Udder Health Management
How to Decrease the Use of Antibiotics in Udder Health Management Jean-Philippe Roy Professor, Bovine ambulatory clinic, Faculté de médecine vétérinaire, Université de Montréal.3200 rue Sicotte, C.P. 5000,
More informationMinna Koivula & Esa Mäntysaari, MTT Agrifood Research Finland, Animal Production Research, Jokioinen, Finland
M6.4. minna.koivula@mtt.fi Pathogen records as a tool to manage udder health Minna Koivula & Esa Mäntysaari, MTT Agrifood Research Finland, Animal Production Research, 31600 Jokioinen, Finland Objectives
More informationPrototheca Mastitis in Dairy Cows
1 Mastitis Control Program for Prototheca Mastitis in Dairy Cows by John Kirk Veterinary Medicine Extension, School of Veterinary Medicine University of California Davis and Roger Mellenberger Department
More informationMilk quality & mastitis - troubleshooting, control program
Milk quality & mastitis - troubleshooting, control program Jim Reynolds, DVM, MPVM University of California, Davis Tulare Veterinary Medicine Teaching and Research Center 18830 Road 112 Tulare, CA 93274
More informationMASTITIS DNA SCREENING
Trusted Dairy Laboratory Services for more than 75 years MASTITIS DNA SCREENING Short Reference Guide Eurofins DQCI 5205 Quincy Street, Mounds View, MN 55112 P: 763-785-0484 F: 763-785-0584 E: DQCIinfo@eurofinsUS.com
More information1. INTRODUCTION. Sayed, M.L. 1, Shell, W.S. 1, Hanan, A. Ahmed 1, Hanan, M. Ibrahim 1, Nasr, E.A. 2 and Ali, A.M. 2
BENHA VETERINARY MEDICAL JOURNAL, VOL. 29, NO. 2:309-318, DECEMBER, 2015 BENHA UNIVERSITY FACULTY OF VETERINARY MEDICINE Efficacy of a locally prepared bovine mastitis vaccine Sayed, M.L. 1, Shell, W.S.
More informationStrep. ag.-infected Dairy Cows
1 Mastitis Control Program for Strep. ag.-infected Dairy Cows by John Kirk Veterinary Medicine Extension, School of Veterinary Medicine University of California Davis and Roger Mellenberger Department
More informationCaused by microorganisms (usually bacteria) that invade the udder, multiply, and produce toxins that are harmful to the mammary gland
MASTITIS PA R T 1 MASTITIS Mast = breast; itis = inflammation Inflammation of the mammary gland Caused by microorganisms (usually bacteria) that invade the udder, multiply, and produce toxins that are
More informationMASTITIS. Therefore, mastitis is an inflammation of the mammary gland.
MASTITIS Mastos = breast itis = inflammation Therefore, mastitis is an inflammation of the mammary gland. Or Reaction to a tissue injury. Therefore, inflammation can and does result in the loss of function
More informationInterpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens
Interpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens Using Your Results Culture results can provide you with valuable decision-making information.
More informationSources of Different Mastitis Organisms and Their Control
Sources of Different Mastitis Organisms and Their Control W. Nelson Philpot Professor Emeritus, Louisiana State University Phone: 318-027-2388; email: philpot@homerla.com Introduction Mastitis is unlike
More informationUsing SCC to Evaluate Subclinical Mastitis Cows
Using SCC to Evaluate Subclinical Mastitis Cows By: Michele Jones and Donna M. Amaral-Phillips, Ph.D. Mastitis is the most important and costliest infectious disease on a dairy farm. A National Mastitis
More informationProper Dry-Off Procedures to Prevent New Infections and Cure Existing Cases of Mastitis. Stephen C. Nickerson University of Georgia
Proper Dry-Off Procedures to Prevent New Infections and Cure Existing Cases of Mastitis Stephen C. Nickerson University of Georgia scn@uga.edu Michelle Arnold, DVM DABVP (Food Animal) Ruminant Extension
More informationMastitis Reminders and Resources LAURA SIEGLE EXTENSION AGENT VIRGINIA COOPERATIVE EXTENSION AMELIA COUNTY
Mastitis Reminders and Resources LAURA SIEGLE EXTENSION AGENT VIRGINIA COOPERATIVE EXTENSION AMELIA COUNTY 4 year old cow (just freshened) comes in with clinical mastitis symptoms. What do you do next?
More informationAdvanced Interherd Course
Advanced Interherd Course Advanced Interherd Training Course... 2 Mastitis... 2 Seasonal trends in clinical mastitis... 2... 3 Examining clinical mastitis origins... 3... 4 Examining dry period performance
More informationLOOKING FOR PROFITS IN MILK QUALITY
LOOKING FOR PROFITS IN MILK QUALITY Richard L. Wallace TAKE HOME MESSAGES Begin monitoring milk quality practices by recording bulk tank data, DHIA somatic cell count (SCC) information, and clinical mastitis
More informationDr. Michelle Arnold, DVM DABVP (Food Animal) Ruminant Extension Veterinarian University of Kentucky Veterinary Diagnostic Laboratory
Dr. Michelle Arnold, DVM DABVP (Food Animal) Ruminant Extension Veterinarian University of Kentucky Veterinary Diagnostic Laboratory Mastitis-Treatment Options and Strategies Treatment Strategies 1 st
More informationThe mastitis situation in Canada where do you stand?
The mastitis situation in Canada where do you stand? Richard Olde Riekerink and Herman Barkema 1 Québec City December 11, 2007 Mastitis Most expensive disease on a dairy farm discarded milk, treatment,
More informationUnderstanding the Basics of Mastitis
publication 404-233 Understanding the Basics of Mastitis G.M. Jones, Professor of Dairy Science and Extension Dairy Scientist, Milk Quality & Milking Management, Virginia Tech T.L. Bailey, Jr., Assistant
More informationEstimate of milk and curd yield loss of sheep and goats with intrammamary infection and its relation to somatic cell count
Available online at www.sciencedirect.com Small Ruminant Research 74 (2008) 221 225 Short communication Estimate of milk and curd yield loss of sheep and goats with intrammamary infection and its relation
More informationSomatic Cell Count as an Indicator of Subclinical Mastitis. Genetic Parameters and Correlations with Clinical Mastitis
Somatic Cell Count as an Indicator of Subclinical Mastitis. Genetic Parameters and Correlations with Clinical Mastitis Morten Svendsen 1 and Bjørg Heringstad 1,2 1 GENO Breeding and A.I. Association, P.O
More informationInterpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens
F-MC-3: Interpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens Source: Laboratory for Udder Health, Minnesota Veterinary Diagnostic Laboratory, University
More informationEmerging Mastitis Threats on the Dairy Pamela Ruegg, DVM, MPVM Dept. of Dairy Science
Emerging Mastitis Threats on the Dairy Pamela Ruegg, DVM, MPVM Dept. of Dairy Science Introduction Mastitis is the most frequent and costly disease of dairy cattle. Losses due to mastitis can be attributed
More informationSection 2: KPI Results for the year ending 31/08/2017
Section 2: KPI Results for the year ending 31/08/2017 Parameter Table 1(a) Summary of Key Performance Indicators derived from analysis of 500 NMR milk recording herds for the year ending 31 st August 2017
More informationGENETICS AND BREEDING
GENETICS AND BREEDING Genetic and Environmental Relationships Among Somatic Cell Count, Bacterial infection, and Clinical Mastitis J. 1. WELLER Institute of Animal Sciences Agricultural Research Organization
More informationMastitis Prevention and Cure Rates in Heifers Treated with Spectramast Dry Cow Therapy and/or Orbeseal Dry Cow Teat Sealant
Mastitis Prevention and Cure Rates in Heifers Treated with Spectramast Dry Cow Therapy and/or Orbeseal Dry Cow Teat Sealant J. R. Booth, F. M. Kautz, and S. C. Nickerson Introduction: Dairy cows are vital
More informationPOSSIBLE PROTECTIVE EFFECT OF AN AUTOVACCINE AGAINST HIGH VIRULENCE STAPHYLOCOCCUS AUREUS IN A RABBIT SKIN INFECTION MODEL
Pathology and Hygiene POSSIBLE PROTECTIVE EFFECT OF AN AUTOVACCINE AGAINST HIGH VIRULENCE STAPHYLOCOCCUS AUREUS IN A RABBIT SKIN INFECTION MODEL Meulemans L. 1 *, Hermans K. 1, Lipinska U. 1, Duchateau
More information, Pamela L. Ruegg
Premiums, Production and Pails of Discarded Milk How Much Money Does Mastitis Cost You? Pamela Ruegg, DVM, MPVM University of Wisconsin, Madison Introduction Profit centered dairy farms strive to maximize
More informationMastitis vaccines in dairy cows: Recent developments and recommendations of application
Veterinary World, EISSN: 2231-0916 Available at www.veterinaryworld.org/vol.10/september-2017/8.pdf REVIEW ARTICLE Open Access Mastitis vaccines in dairy cows: Recent developments and recommendations of
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BLUEVAC BTV8 suspension for injection for cattle and sheep 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of
More informationKey words: mastitis, dairy, fertility, animal reproduction
J. Dairy Sci. 98 :1 15 http://dx.doi.org/10.3168/jds.2014-8997 american dairy Science association, 2015. The association between occurrence and severity of subclinical and clinical mastitis on pregnancies
More informationFinnzymes Oy. PathoProof Mastitis PCR Assay. Real time PCR based mastitis testing in milk monitoring programs
PathoProof TM Mastitis PCR Assay Mikko Koskinen, Ph.D. Director, Diagnostics, Finnzymes Oy Real time PCR based mastitis testing in milk monitoring programs PathoProof Mastitis PCR Assay Comparison of the
More informationLast 2-3 months of lactation
Last 2-3 months of lactation Guideline 14 15 Decide dry cow management strategy Consider culling persistently infected cows CellCheck Farm CellCheck Guidelines Farm for Guidelines Mastitis Control for
More informationThe organism Infection process Tissue reaction SCC response Prevention Treatment
Prevention and control of Staphylococcus aureus mastitis The organism Infection process Tissue reaction SCC response Prevention Treatment Staphylococcus aureus: Gram-positive Staphylo = Coccus = Cluster
More informationPremiums, Production and Pails of Discarded Milk How Much Money Does Mastitis Cost You? Pamela Ruegg, DVM, MPVM University of Wisconsin, Madison
Premiums, Production and Pails of Discarded Milk How Much Money Does Mastitis Cost You? Pamela Ruegg, DVM, MPVM University of Wisconsin, Madison Introduction Profit centered dairy farms strive to maximize
More informationUniversity of Missouri Extension Using the California Mastitis Test
University of Missouri Extension Using the California Mastitis Test Robert T. Marshall and J. E. Edmondson Department of Food Science and Nutrition Barry Steevens Department of Animal Sciences One of the
More informationJ. Dairy Sci. 90: doi: /jds American Dairy Science Association, 2007.
J. Dairy Sci. 90:4282 4288 doi:10.3168/jds.2007-0160 American Dairy Science Association, 2007. Comparison of J5 Vaccinates and Controls for Incidence, Etiologic Agent, Clinical Severity, and Survival in
More informationLactation. Macroscopic Anatomy of the Mammary Gland. Anatomy AS 1124
Lactation AS 1124 Macroscopic Anatomy of the Mammary Gland Species differences in numbers and locations of glands inguinal - caudal to the abdomen, between the hind legs (cow, mare, ewe) abdominal - along
More informationA New Index for Mastitis Resistance
A New Index for Mastitis Resistance F. Miglior, * A. Koeck, * G. Kistemaker and B.J. Van Doormaal * Centre for Genetic Improvement of Livestock, University of Guelph Canadian Dairy Network Guelph, Ontario,
More informationQuality Milk on Pasture Based Dairy Farms. Scott E. Poock, DVM University of Missouri Clinical Assistant Professor DABVP Beef and Dairy Cattle
Quality Milk on Pasture Based Dairy Farms Scott E. Poock, DVM University of Missouri Clinical Assistant Professor DABVP Beef and Dairy Cattle Overview Present Status of Industry Why Milk Quality is Important
More informationNorthern NY Agricultural Development Program 2016 Project Report
Northern NY Agricultural Development Program 2016 Project Report Evaluation of Powdered Teat Dip Post Milking Under Cold Weather Conditions in Northern New York Project Leader(s): Kimberley Morrill, PhD,
More informationVeterinaria.com.pt 2009; Vol. 1 Nº 1: e13 (publicação inicial em Julho de 2008) Disponível em
Veterinaria.com.pt 2009; Vol. 1 Nº 1: e13 (publicação inicial em Julho de 2008) Disponível em http://www.veterinaria.com.pt/media//dir_27001/vcp1-1-e13.pdf Evolution of CMSCC in Intramammary Staphylococcus
More informationOutline MILK QUALITY AND MASTITIS TREATMENTS ON ORGANIC 2/6/12
MILK QUALITY AND MASTITIS TREATMENTS ON ANIC AND SMALL VENTIONAL DAIRY FARMS Roxann M. Richert* 1, Pamela L. Ruegg 1, Mike J. Gamroth 2, Ynte H. Schukken 3, Kellie M. Cicconi 3, Katie E. Stiglbauer 2 1
More informationMastitis control in bred heifers: Use of dry cow therapy and teat sealant for curing existing intramammary infections and preventing new ones
Mastitis control in bred heifers: Use of dry cow therapy and teat sealant for curing existing intramammary infections and preventing new ones Abstract S. C. Nickerson, F. M. Kautz, A. E. Harding, J. R.
More informationManagement Practices and Intramammary Infections: New Ideas for an Old Problem
Management Practices and Intramammary Infections: New Ideas for an Old Problem (Recent data from a pan-canadian study) Simon Dufour, Daniel Scholl, Anne-Marie Christen, Trevor DeVries University of Montreal,
More informationS. P. Oliver, R. A. Almeida, B. E. Gillespie, S. J. Ivey, H. Moorehead, P. Lunn, H. H. Dowlen, D. L. Johnson, and K. C. Lamar
S. P. Oliver, R. A. Almeida, B. E. Gillespie, S. J. Ivey, H. Moorehead, P. Lunn, H. H. Dowlen, D. L. Johnson, and K. C. Lamar Efficacy of Extended Pirlimycin Therapy for Treatment of Experimentally Induced
More informationSummary. Table 1. Estimated infection prevalence and losses in milk production associated with elevated bulk tank somatic cell counts.
publication 404-228 Guidelines for Using the DHI Somatic Cell Count Program G. M. Jones, Professor of Dairy Science and Extension Dairy Scientist, Milk Quality & Milking Management, Virginia Tech Summary
More informationHerd health challenges in high yielding dairy cow systems
Herd health challenges in high yielding dairy cow systems Robert Smith robsmith@liv.ac.uk The big three diseases Fertility Lameness Mastitis Energy balance and body condition Ruminal acidosis and abomasal
More informationAUTOMATIC MILKING SYSTEMS AND MASTITIS
AUTOMATIC MILKING SYSTEMS AND MASTITIS Kees de Koning Manager Dairy Campus, Wageningen University & Research Centre, Boksumerdyk 11, 9084 AA Leeuwarden, the Netherlands, Internet: www.dairycampus.com Contact:
More informationEXCEDE Sterile Suspension
VIAL LABEL MAIN PANEL PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN READ SAFETY DIRECTIONS FOR ANIMAL TREATMENT ONLY EXCEDE Sterile Suspension 200 mg/ml CEFTIOFUR as Ceftiofur Crystalline Free
More informationAssessment of the Impact of Somatic Cell Count on Functional Longevity in Holstein and Jersey Cattle Using Survival Analysis Methodology
J. Dairy Sci. 88:804 811 American Dairy Science Association, 2005. Assessment of the Impact of Somatic Cell Count on Functional Longevity in Holstein and Jersey Cattle Using Survival Analysis Methodology
More informationEvaluation of intervention strategies for subclinical and clinical mastitis
Evaluation of intervention strategies for subclinical and clinical mastitis CPH Cattle seminar, 31. October 2018 Maya Gussmann, Wilma Steeneveld, Carsten Kirkeby, Henk Hogeveen, Michael Farre, Tariq Halasa
More informationDairy Science 305 Lactation Physiology Fall 2014 Syllabus
Dairy Science 305 Lactation Physiology Fall 2014 Syllabus Instructor: Laura Hernandez, Ph.D. Office: 864 Animal Science Phone: 263-9867 Email: llhernandez@wisc.edu Office Hours: By appointment Lecture:
More information2012 Indiana Regional Dairy Meetings. Purdue University College of Veterinary Medicine Dr. Jon Townsend Dairy Production Medicine
2012 Indiana Regional Dairy Meetings Purdue University College of Veterinary Medicine Dr. Jon Townsend Dairy Production Medicine Focusing on the selection of the correct animals, diagnosis of causative
More informationManaging Mastitis in Dairy Heifers to Improve Overall Herd Health
Managing Mastitis in Dairy Heifers to Improve Overall Herd Health Stephen C. Nickerson, Professor; Felicia M. Kautz, Research Associate; and Elizabeth L. Nace, Graduate Research Assistant Animal and Dairy
More informationIMMUNOSTIMULATING EFFECTS OF A COMMERCIAL FEED SUPPLEMENT IN DAIRY HEIFERS VACCINATED WITH A STAPHYLOCOCCUS AUREUS BACTERIN VALERIE JOANNE EUBANKS
IMMUNOSTIMULATING EFFECTS OF A COMMERCIAL FEED SUPPLEMENT IN DAIRY HEIFERS VACCINATED WITH A STAPHYLOCOCCUS AUREUS BACTERIN by VALERIE JOANNE EUBANKS (Under the direction of Stephen C. Nickerson) ABSTRACT
More information= 0.5 mg. In vitro toxin neutralisation test based on haemolysis of sheep erythrocytes. For a full list of excipients, see section 6.1.
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Covexin 8 Suspension for injection for sheep and cattle 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: Potency value/quantity/ml C. perfringens
More informationMilking behaviour in dairy cows naturally infected with clinical mastitis
Milking behaviour in dairy cows naturally infected with clinical mastitis Katrine K. Fogsgaard Torben W. Bennedsgaard Mette S. Herskin DEPT. OF ANIMAL SCIENCE AU AARHUS UNIVERSITY August 28 th 2014 1 BACKGROUND
More informationChronMast - a model to study functional genetic variation of mastitis susceptibility
ChronMast - a model to study functional genetic variation of mastitis susceptibility M. Meyerholz 1,2, A. Heimes 3, J. Brodhagen 3, L. Rohmeier 2, T. Eickhoff 1, S. Jander 1, A. Hülsebusch 1, R. Weikard
More informationActions and Outcomes of Wisconsin Dairy Farms Completing Milk Quality Teams
J. Dairy Sci. 88:2672 2680 American Dairy Science Association, 2005. Actions and Outcomes of Wisconsin Dairy Farms Completing Milk Quality Teams A. C. O. Rodrigues and P. L. Ruegg Department of Dairy Science,
More informationBovine mastitis caused by coagulase-negative staphylococci
Department of Production Animal Medicine Faculty of Veterinary Medicine University of Helsinki Finland Bovine mastitis caused by coagulase-negative staphylococci by Suvi Taponen ACADEMIC DISSERTATION To
More informationCheck that milk is suitable to go in the vat
TECHNOTE 3 Check that milk is suitable to go in the vat CALVING For milk quality reasons, all cows must have their colostrum milk withheld from the vat for at least eight milkings after calving. Colostrum
More informationTHIS ARTICLE IS SPONSORED BY THE MINNESOTA DAIRY HEALTH CONFERENCE.
THIS ARTICLE IS SPONSORED BY THE MINNESOTA DAIRY HEALTH CONFERENCE. ST. PAUL, MINNESOTA UNITED STATES OF MINNESOTA Heifer Mastitis Philip M. Sears, DVM, PhD, and David J. Wilson, DVM, MS Cornell University
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate
SUMMARY OF PRODUCT CHARACTERISTICS AN: 00221/2013 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Lincocin Forte S Intramammary Solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Lincomycin
More information